111 related articles for article (PubMed ID: 33016802)
1. Clinical course of Crohn's disease in a population-based cohort in Uppsala County followed for 10 years.
Rönnblom A; Karlbom U
Scand J Gastroenterol; 2020 Nov; 55(11):1301-1307. PubMed ID: 33016802
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of Crohn's disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005-2009
Rönnblom A; Holmström T; Karlbom U; Tanghöj H; Thörn M; Sjöberg D
Scand J Gastroenterol; 2017 Jan; 52(1):81-86. PubMed ID: 27632773
[TBL] [Abstract][Full Text] [Related]
3. Complications and adverse effects related to surgical and medical treatment in patients with inflammatory bowel disease in a prospectively recruited population-based cohort.
Rönnblom A; Ljunggren Ö; Karlbom U
Scand J Gastroenterol; 2021 Nov; 56(11):1296-1303. PubMed ID: 34369245
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcome of ulcerative colitis during the first 10 years after diagnosis in a prospectively followed population-based cohort.
Rönnblom A; Karlbom U
Scand J Gastroenterol; 2021 Apr; 56(4):403-409. PubMed ID: 33577739
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease prognosis and early immunomodulator therapy: Results from the CONNECT study.
Kim B; Cheon JH; Moon HJ; Park YR; Ye BD; Yang SK; Seo GS; Jang BI; Kim YS; Kim JS; Han DS; Kim YH; Kim WH
J Gastroenterol Hepatol; 2016 Jan; 31(1):126-32. PubMed ID: 26406334
[TBL] [Abstract][Full Text] [Related]
7. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.
Burisch J; Bergemalm D; Halfvarson J; Domislovic V; Krznaric Z; Goldis A; Dahlerup JF; Oksanen P; Collin P; de Castro L; Hernandez V; Turcan S; Belousova E; D'Incà R; Sartini A; Valpiani D; Giannotta M; Misra R; Arebi N; Duricova D; Bortlik M; Gatt K; Ellul P; Pedersen N; Kjeldsen J; Andersen KW; Andersen V; Katsanos KH; Christodoulou DK; Sebastian S; Barros L; Magro F; Midjord JM; Nielsen KR; Salupere R; Kievit HA; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Kaimakliotis IP; Schwartz D; Odes S; Lakatos L; Lakatos PL; Langholz E; Munkholm P;
United European Gastroenterol J; 2020 Oct; 8(8):949-960. PubMed ID: 32715989
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
9. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
Kristensen VA; Cvancarova M; Høivik ML; Moum B; Vatn MH
Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
[No Abstract] [Full Text] [Related]
10. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
[TBL] [Abstract][Full Text] [Related]
11. [The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].
Golovics PA; Lakatos PL; Dávid G; Pandur T; Erdélyi Z; Horváth A; Mester G; Balogh M; Szipocs I; Molnár C; Komáromi E; Lovász BD; Szathmári M; Kiss LS; Lakatos L
Orv Hetil; 2012 Apr; 153(14):541-52. PubMed ID: 22450143
[TBL] [Abstract][Full Text] [Related]
12. The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.
Zhulina Y; Udumyan R; Tysk C; Montgomery S; Halfvarson J
Scand J Gastroenterol; 2016 Mar; 51(3):304-13. PubMed ID: 26448101
[TBL] [Abstract][Full Text] [Related]
13. Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease.
Peyrin-Biroulet L; Harmsen WS; Tremaine WJ; Zinsmeister AR; Sandborn WJ; Loftus EV
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1439-44. PubMed ID: 27155552
[TBL] [Abstract][Full Text] [Related]
14. Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.
Burisch J; Kiudelis G; Kupcinskas L; Kievit HAL; Andersen KW; Andersen V; Salupere R; Pedersen N; Kjeldsen J; D'Incà R; Valpiani D; Schwartz D; Odes S; Olsen J; Nielsen KR; Vegh Z; Lakatos PL; Toca A; Turcan S; Katsanos KH; Christodoulou DK; Fumery M; Gower-Rousseau C; Zammit SC; Ellul P; Eriksson C; Halfvarson J; Magro FJ; Duricova D; Bortlik M; Fernandez A; Hernández V; Myers S; Sebastian S; Oksanen P; Collin P; Goldis A; Misra R; Arebi N; Kaimakliotis IP; Nikuina I; Belousova E; Brinar M; Cukovic-Cavka S; Langholz E; Munkholm P;
Gut; 2019 Mar; 68(3):423-433. PubMed ID: 29363534
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for surgery and postoperative recurrence: analysis of a south China cohort with Crohn's disease.
Gao X; Yang RP; Chen MH; Xiao YL; He Y; Chen BL; Hu PJ
Scand J Gastroenterol; 2012 Oct; 47(10):1181-91. PubMed ID: 22845663
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
[TBL] [Abstract][Full Text] [Related]
18. Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.
Sjöberg D; Holmström T; Larsson M; Nielsen AL; Holmquist L; Ekbom A; Rönnblom A
J Crohns Colitis; 2014 Mar; 8(3):215-22. PubMed ID: 24035547
[TBL] [Abstract][Full Text] [Related]
19. The effect of immunomodulators and biologics on indication for surgical bowel resection in children with Crohn's disease.
Zimmerman LA; Shamberger RC; Valim C; Bousvaros A
Inflamm Bowel Dis; 2014 Jun; 20(6):1015-20. PubMed ID: 24788215
[TBL] [Abstract][Full Text] [Related]
20. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study).
Henriksen M; Jahnsen J; Lygren I; Aadland E; Schulz T; Vatn MH; Moum B;
Scand J Gastroenterol; 2007 May; 42(5):602-10. PubMed ID: 17454881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
